Publication | Open Access

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial

OncologyPancreatic CancerPharmacologyPharmacological AscorbatePharmacotherapyCancer TreatmentNode-positive Pancreatic CancerMedicine